Hydroxamates as carbonic anhydrase inhibitors

Hydroxamic Acids: A Unique Family of Chemicals with Multiple Biological Activities

Volumn 9783642381119, Issue , 2013, Pages 55-69

  Supuran, Claudiu T ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Carbonic anhydrase inhibitors; Carbonic anhydrases; Hydroxamates; Hydroxyureas

Indexed keywords

AMIDES; AMINO ACIDS; ASCORBIC ACID; ELECTROLYTES; ENZYME INHIBITION; MAMMALS; PHYSIOLOGY; SULFUR COMPOUNDS; ZINC;

ACID MOIETY; AMINO-ACIDS; CARBONIC ANHYDRASE INHIBITOR; HIGH-AFFINITY INHIBITORS; HYDROXAMATE; HYDROXYUREAS; PH-REGULATION; PHYSIOLOGICAL FUNCTIONS; SALIENT FEATURES; SULPHONAMIDES;

CARBONIC ANHYDRASE;

EID: 84929881228     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-3-642-38111-9_3     Document Type: Chapter

References (29)

1. Alterio V, Di Fiore A, D'Ambrosio K et al (2012) Multiple binding modes of inhibitors to carbonic anhydrases: how to design specific drugs targeting 15 different isoforms? Chem Rev 112:4421-4468
2. Borkakoti N (2000) Structural studies of matrix metalloproteinases. J Mol Med 78:261-268
3. Borkakoti N, Winkler FK, Williams DH et al (1994) Structure of the catalytic domain of human fibroblast collagenase complexed with an inhibitor. Nat Struct Biol 1:106-110
4. Bottomley KM, Johnson WH, Walter DS (1998) Matrix metalloproteinase inhibitors in arthritis. J Enz Inhib 13:79-102
5. Briganti F, Mangani S, Scozzafava A et al (1999) Carbonic anhydrase catalyzes cyanamide hydration to urea: is it mimicking the physiological reaction? J Biol Inorg Chem 4:528-536
6. Christianson DW, Ippolito JA (1991) Structure-function relationship between the carbonic anhydrases and the zinc proteases. In: Botrè F, Gros G, Storey BT (eds) Carbonic Anhydrase. VCH, New York, pp 95-110
7. Coleman JE (1998) Zinc enzymes. Curr Opin Chem Biol 2:222-234
8. Di Fiore A, Maresca A, Supuran CT, De Simone G (2012) Hydroxamate represents a versatile zinc binding group for the development of new carbonic anhydrase inhibitors. Chem Commun 48:8838-8840
9. Gupta SP, Maheswaran V, Pande V, Kumar D (2003) A comparative QSAR study on carbonic anhydrase and matrix metalloproteinase inhibition by sulfonylated amino acid hydroxamates. J Enzyme Inhib Med Chem 18:7-13
10. Lovejoy B, Welch AR, Carr S et al (1999) Crystal structures of MMP-1 and -13 reveal the structural basis for selectivity of collagenase inhibitors. Nat Struct Biol 6:217-221
11. Marques SM, Nuti E, Rossello A et al (2008) Dual inhibitors of matrix metalloproteinases and carbonic anhydrases: iminodiacetyl-based hydroxamate-benzenesulfonamide conjugates. J Med Chem 51:7968-7979
12. Nagase H, Woessner JF (1999) Matrix metalloproteinases. J Biol Chem 274:21491-21494
13. Neri D, Supuran CT (2011) Interfering with pH regulation in tumours as a therapeutic strategy. Nat Rev Drug Discov 10:767-777
14. Santos MA, Marques S, Vullo D et al (2007) Carbonic anhydrase inhibitors. Inhibition of cytosolic/tumor-associated isoforms I, II and IX with iminodiacetic carboxylates/hydroxamates also incorporating benzenesulfonamide moieties. Bioorg Med Chem Let 17:1538-1543
15. Scolnick LR, Clements AM, Liao J et al (1997) Novel binding mode of hydroxamate inhibitors to human carbonic anhydrase II. J Am Chem Soc 119:850-851
16. Scozzafava A, Menabuoni L, Mincione F et al (1999) Carbonic anhydrase inhibitors: synthesis of water-soluble, topically effective intraocular pressure lowering aromatic/heterocyclic sulfonamides containing cationic or anionic moieties: is the tail more important than the ring? J Med Chem 42:2641-2650
17. Scozzafava A, Supuran CT (2000a) Carbonic anhydrase and matrix metalloproteinase inhibitors. Sulfonylated amino acid hydroxamates with MMP inhibitory properties act as efficient inhibitors of carbonic anhydrase isozymes I, II and IV, and N-hydroxysulfonamides inhibit both these zinc enzymes. J Med Chem 43:3677-3687
18. Scozzafava A, Supuran CT (2000b) Protease inhibitors. Part 5. Alkyl/arylsulfonyl- and arylsulfonylureido-/arylureido-glycine hydroxamate inhibitors of Clostridium histolyticum collagenase. Eur J Med Chem 35:299-307
19. Scozzafava A, Supuran CT (2000c) Protease inhibitors. Part 9. Synthesis of Clostridium histolyticum collagenase inhibitors incorporating sulfonyl-L-alanine hydroxamate moieties. Bioorg Med Chem Lett 10:499-502
20. Scozzafava A, Supuran CT (2003) Hydroxyurea is a carbonic anhydrase inhibitor. Bioorg Med Chem 11:2241-2246
21. Supuran CT (2008) Carbonic anhydrases: novel therapeutic applications for inhibitors and activators. Nat Rev Drug Discov 7:168-181
22. Supuran CT (2010) Carbonic anhydrase inhibitors. Bioorg Med Chem Lett 20:3467-3474
23. Supuran CT (2011) Carbonic anhydrase inhibitors and activators for novel therapeutic applications. Future Med Chem 3:1165-1180
24. Supuran CT (2012) Structure-based drug discovery of carbonic anhydrase inhibitors. J Enzyme Inhib Med Chem 27:759-772
25. Supuran CT, Scozzafava A (2002) Matrix metalloproteinases (MMPs). In proteinase and peptidase inhibition: recent potential targets for drug development, Smith HJ, Simons C, Eds., Taylor & Francis, London, pp 35-61
26. Supuran CT, Winum JY (2009) Introduction to zinc enzymes as drug targets. In: Supuran CT, Winum JY (eds) Drug Design of Zinc-Enzyme Inhibitors: Functional, Structural, and Disease Applications. Wiley, Hoboken, pp 3-12
27. Temperini C, Innocenti A, Scozzafava A, Supuran CT (2006) N-Hydroxyurea-a versatile zinc binding function in the design of metalloenzyme inhibitors. Bioorg Med Chem Lett 16:4316-4320
28. Van Wart HE, Steinbrink DR (1981) A continuous spectrophotometric assay for Clostridium histolyticum collagenase. Anal Biochem 113:156-165
29. Whittaker M, Floyd CD, Brown P, Gearing AJH (1999) Design and therapeutic application of matrix metalloproteinase inhibitors. Chem Rev 99:2735-2776